(Q34303766)

1 August 2017

title

The mTOR-inhibitor rapamycin mediates proteinuria in nephrotoxic serum nephritis by activating the innate immune response (English)

1 reference

1 August 2017

1 reference

A H Kirsch

1

1 reference

1 August 2017

V Riegelbauer

2

1 reference

1 August 2017

A Tagwerker

3

1 reference

1 August 2017

M Rudnicki

4

1 reference

1 August 2017

A R Rosenkranz

5

1 reference

1 August 2017

K Eller

6

1 reference

1 August 2017

publication date

13 June 2012

1 reference

American Journal of Physiology - Renal Physiology

1 August 2017

published in

1 reference

1 August 2017

volume

303

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

F569-75

1 reference

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

The role of VEGF-A in glomerular development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Differential effects of rapamycin in anti-GBM glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

The TSC-mTOR signaling pathway regulates the innate inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00180.2012

10.1152/AJPRENAL.00180.2012

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference